StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Tandem Diabetes Care (TNDM) PT Lowered to $20 at Mizuho
July 15, 2026 6:40 AM
Mizuho analyst Anthony Petrone lowered the price target on Tandem Diabetes Care (NASDAQ:
TNDM
) to $20.00 (from $24.00) while maintaining a Neutral rating.
Categories
Analyst PT Change